Cutler Group’s Pacira BioSciences PCRX Stock Holding History

Cutler Group’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,500	Closed	-$20K	–	5346
2022 Q2	$20K	Buy	+1,500	New	+$98.3K	﹤0.01%	2680
2019 Q2	–	Sell	-1,000	Closed	-$5K	–	4655
2019 Q1	$5K	Sell	1,000 -2,500	-71%	-$97.6K	﹤0.01%	2930
2018 Q4	$2K	Hold	3,500	–	–	﹤0.01%	3405
2018 Q3	$2K	Buy	+3,500	New	+$151K	﹤0.01%	3544
2018 Q2	–	Sell	-48,000	Closed	-$100K	–	4688
2018 Q1	$100K	Buy	48,000 +42,200	+728%	+$1.5M	0.01%	1176
2017 Q4	$26K	Buy	5,800 +5,000	+625%	+$198K	﹤0.01%	2344
2017 Q3	$5K	Sell	800 -5,800	-88%	-$233K	﹤0.01%	4407
2017 Q2	$8K	Sell	6,600 -5,400	-45%	-$251K	﹤0.01%	4397
2017 Q1	$31K	Sell	12,000 -10,900	-48%	-$471K	﹤0.01%	2872
2016 Q4	$124K	Sell	22,900 -14,600	-39%	-$487K	﹤0.01%	1715
2016 Q3	$226K	Buy	37,500 +32,500	+650%	+$1.27M	0.01%	1104
2016 Q2	$95K	Sell	5,000 -4,300	-46%	-$211K	﹤0.01%	1734
2016 Q1	$141K	Buy	9,300 +2,300	+33%	+$135K	0.01%	1293
2015 Q4	$53K	Buy	+7,000	New	+$396K	﹤0.01%	2390

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Loomis, Sayles & Company

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return